GlobalData on MSN11 个月
Nyxoah’s nerve stimulation device meets endpoints in sleep apnoea study
Nyxoah’s hypoglossal nerve stimulation system, Genio, met the co-primary endpoints at 12 months in the pivotal DREAM trial in ...
来自MSN2 个月
First UK patients fitted with app-controlled nerve stimulator for sleep apnoea
It comes as UCLH became the first centre in the UK to offer sleep apnoea patients a choice of nerve stimulators – the Genio Nyxoah or the Inspire implant. Both devices stimulate the hypoglossal ...
Kaleido Scope9 年
Clinical Trials
Principal Investigator: Kirk Withrow, M.D. A multicenter study to assess the safety and effectiveness of the Genio®️ dual-sided hypoglossal nerve stimulation system for the treatment of obstructive ...